Psychae Institute
The startup develops registered medical treatments using psychedelic compounds such as psilocybin, MDMA, and DMT for mental disorders and other diseases. Through clinical and pre-clinical research, the company aims to establish evidence-based therapeutic models that enhance patient access to these psychedelic therapies.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$40MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops registered medical treatments using psychedelic compounds such as psilocybin, MDMA, and DMT for mental disorders and other diseases. Through clinical and pre-clinical research, the company aims to establish evidence-based therapeutic models that enhance patient access to these psychedelic therapies.